Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 13 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort studyOwen, C.; Ngian, G.; Elford, K.; Moore, O.; Stevens, W.; Nikpour, M.; Rabusa, C.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Sturgess, A.; Tymms, K.; Youssef, P.; Sahhar, J.
2014The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosisMorrisroe, K.; Stevens, W.; Nandurkar, H.; Prior, D.; Thakkar, V.; Roddy, J.; Zochling, J.; Sahhar, J.; Tymms, K.; Sturgess, A.; Major, G.; Kermeen, F.; Hill, C.; Walker, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.
2014Mycophenolate mofetil versus azathioprine in scleroderma-associated interstitial lung disease: results from the Australian Scleroderma Cohort StudyOwen, C.; Ngian, G.; Elford, K.; Moore, O.; Nikpour, M.; Stevens, W.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Nash, P.; Sturgess, A.; Sahhar, J.; 2014 ACR/ARHP Annual Meeting (14 Nov 2014 - 19 Nov 2014 : Boston, MA)
2014Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosisQuinlivan, A.; Thakkar, V.; Stevens, W.; Prior, D.; Rabusa, C.; Youssef, P.; Gabbay, E.; Roddy, J.; Walker, J.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Hill, C.; Rischmueller, M.; Proudman, S.; Nikpour, M.; 3rd Systemic Sclerosis World Congress (6 Feb 2014 - 8 Feb 2014 : Rome, Italy)
2014Associations between HLA DRB1 alleles and autoantibodies in systemic sclerosisLester, S.; Patterson, K.; Walker, J.; Charlesworth, J.; Stankovich, J.; Stevens, W.; Sahhar, J.; Nash, P.; Roddy, J.; Hill, C.; Nikpour, M.; Rischmueller, M.; Proudman, S.; Brown, M.; Zochling, J.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania)
2014Autoantibody associations among a well-characterized Australian systemic sclerosis (SSc) cohortPatterson, K.; Roberts-Thomson, P.; Lester, S.; Proudman, S.; Rischmueller, M.; Stevens, W.; Mandana, N.; Zochling, J.; Sahhar, J.; Nash, P.; Roddy, J.; Hill, C.; Walker, J.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania)
2014Mycophenolate mofetil versus azathioprine in scleroderma-associated interstitial lung disease: results from the Australian Scleroderma Cohort StudyOwen, C.; Ngian, G.; Moore, O.; Stevens, W.; Proudman, S.; Roddy, J.; Zochling, J.; Nash, P.; Hill, C.; Sturgess, A.; Sahhar, J.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania)
2014Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosisQuinlivan, A.; Thakkar, V.; Stevens, W.; Prior, D.; Rabusa, C.; Youssef, P.; Gabbay, E.; Roddy, J.; Walker, J.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Hill, C.; Rischmueller, M.; Proudman, S.; Nikpour, M.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania)
2020Incidence, risk factors and outcomes of cancer in systemic sclerosisMorrisroe, K.; Hansen, D.; Huq, M.; Stevens, W.; Sahhar, J.; Ngian, G.-S.; Ferdowsi, N.; Hill, C.; Roddy, J.; Walker, J.; Proudman, S.; Nikpour, M.
2015Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (Scleroderma) cohort using principal components analysisPatterson, K.; Roberts-Thomson, P.; Lester, S.; Tan, J.; Hakendorf, P.; Rischmueller, M.; Zochling, J.; Sahhar, J.; Nash, P.; Roddy, J.; Hill, C.; Nikpour, M.; Stevens, W.; Proudman, S.; Walker, J.